Influence of the Mediterranean and Ketogenic Diets on cognitive status and decline : a narrative review |
|
Author: | Vinciguerra, Federica1; Graziano, Marco1; Hagnäs, Maria1,2,3; |
Organizations: |
1Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Medical Center, Via Palermo 636, 95122 Catania, Italy 2Center for Life Course Health Research, University of Oulu, Aapistie 5/PO Box 5000, 90014 Oulu, Finland 3Rovaniemi Health Center, Koskikatu 25, 96200 Rovaniemi, Finland
4Diabetes, Obesity and Dietetic Center, Garibaldi Medical Center, Via Palermo 636, 95122 Catania, Italy
|
Format: | article |
Version: | published version |
Access: | open |
Online Access: | PDF Full Text (PDF, 0.7 MB) |
Persistent link: | http://urn.fi/urn:nbn:fi-fe2020070847152 |
Language: | English |
Published: |
Multidisciplinary Digital Publishing Institute,
2020
|
Publish Date: | 2020-07-08 |
Description: |
AbstractAlzheimer’s disease (AD) is the most common form of senile dementia, accounting for up to 70% of dementia cases. AD is a slowly progressive disease, which causes global mental deterioration by affecting various cognitive areas. A growing body of evidence has demonstrated that lifestyle habits and nutritional patterns could delay the natural course of the neurodegeneration process. There is no single dietary pattern unequivocally proven to prevent AD. Nevertheless, epidemiological data suggest that by adopting several dietary habits, especially if accompanied with a healthy lifestyle, the negative consequences of AD could potentially be delayed. Alongside with others, two specific eating patterns have been well investigated concerning their potential beneficial effect on cognitive status: the Mediterranean diet (MedDi) and the Ketogenic Diet (KD). Despite the different underlying mechanisms, both of them have demonstrated a fairly profitable role in reducing or delaying cognitive impairment. The aim of the present narrative review is to overview the existing research on the efficacy of MedDi and KD against AD-related cognitive decline, focusing on the proposed protective mechanisms of action. Although the current knowledge on this complex topic does not allow us, at this point, to make exhaustive conclusions, this information could be of help in order to better characterize the possible role of MedDi and KD as nonpharmacological therapies in the treatment of AD and, more generically, of neurodegenerative disorders. see all
|
Series: |
Nutrients |
ISSN: | 2072-6643 |
ISSN-E: | 2072-6643 |
ISSN-L: | 2072-6643 |
Volume: | 12 |
Issue: | 4 |
Article number: | 1019 |
DOI: | 10.3390/nu12041019 |
OADOI: | https://oadoi.org/10.3390/nu12041019 |
Type of Publication: |
A2 Review article in a scientific journal |
Field of Science: |
3141 Health care science |
Subjects: | |
Copyright information: |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
https://creativecommons.org/licenses/by/4.0/ |